除颤前呼气末二氧化碳与院外心脏骤停除颤成功的关系:一项观察性队列研究
该研究为观察性队列研究,纳入加拿大安大略省2018年1月1日至2019年12月31日院外心脏骤停且初始心律为室颤的患者,评估除颤前ETCO2读数与后续2分钟脉搏检查时除颤结局的关系,并校正复苏期间使用的气道类型。共153例患者纳入分析,实施904次电击,其中401次电击有除颤前ETCO2测量。多因素分析显示,首次记录的除颤前ETCO2与室颤终止(校正OR 0.99,95%CI 0.97至1.02,p=0.57)或ROSC(校正OR 1.00,95%CI 0.97至1.03,p=0.94)均无关联。作者结论认为,在同时纳入基础与高级气道的分析中,除颤前ETCO2与室颤终止或ROSC无关,其作用需仔细考虑复苏期间使用的气道类型。
要点
- 在153例初始室颤的院外心脏骤停患者中,401次电击有除颤前ETCO2测量,多因素分析显示ETCO2与室颤终止无关(校正OR 0.99,95%CI 0.97至1.02,p=0.57)。
- 同一分析中,除颤前ETCO2与ROSC亦无关(校正OR 1.00,95%CI 0.97至1.03,p=0.94)。
- 按后续心律分组,持续性室颤组除颤前ETCO2为32.2 mm Hg(4.29 kPa)(±15.8 mm Hg(2.11 kPa)),无脉电活动组为32.8 mm Hg(4.37 kPa)(±17.1 mm Hg(2.30 kPa)),心搏停止组为32.4 mm Hg(4.32 kPa)(±20.6 mm Hg(2.75 kPa)),ROSC组为32.5 mm Hg(4.33 kPa)(±15.3
- 基础气道(球囊面罩)测得的ETCO2低于高级气道(声门上气道和气管插管):30.5 mm Hg(4.06 kPa)(±14.4 mm Hg(1.92 kPa))vs 42.1 mm Hg(5.61 kPa)(±22.5 mm Hg(3.00 kPa)),校正方差分析p<0.01。
- 首次ETCO2读数来自球囊面罩者134例,来自高级气道者19例。
适用人群与场景
- 加拿大安大略省2018年1月1日至2019年12月31日院外心脏骤停且初始心律为室颤的患者,数据来自院前患者记录和除颤器文件。
诊断标准与关键阈值
- 初始心律为室颤的院外心脏骤停。
- 除颤前ETCO2测量值,按每次电击前读数与后续2分钟脉搏检查时的心律(室颤、心搏停止、无脉电活动或ROSC)对应分析。
研究设计与关键结果
- 研究类型为观察性队列研究,共摘录269例,其中153例有除颤前ETCO2测量并纳入分析;这些病例共实施904次电击,44.4%(n=401)的电击有除颤前ETCO2测量。
- 首次ETCO2读数来自球囊面罩者134例,来自高级气道者19例;球囊面罩测得的ETCO2低于高级气道:30.5 mm Hg(4.06 kPa)(±14.4 mm Hg(1.92 kPa))vs 42.1 mm Hg(5.61 kPa)(±22.5 mm Hg(3.00 kPa)),校正方差分析p<0.01。
- 在401次有ETCO2读数的电击中,后续心律为持续性室颤、无脉电活动、心搏停止或ROSC的各组除颤前ETCO2无差异:持续性室颤32.2 mm Hg(4.29 kPa)(±15.8 mm Hg(2.11 kPa)),无脉电活动32.8 mm Hg(4.37 kPa)(±17.1 mm Hg(2.30 kPa)),心搏停止32.4 mm Hg(4.32 kPa)(±20.6 mm Hg(2.75 kPa)),ROSC 32.5 mm Hg(4.33 kPa)(±15.3 mm Hg(2.04 kPa)),方差分析p=0.99。
- 多因素分析使用首次除颤前ETCO2,无论作为连续变量还是分类变量,均与后续电击的室颤终止无关(校正OR 0.99,95%CI 0.97至1.02,p=0.57),与ROSC也无关(校正OR 1.00,95%CI 0.97至1.03,p=0.94)。
证据类型、等级与局限
- 证据类型:观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,当分析中纳入基础与高级气道时,除颤前ETCO2测量与室颤终止或ROSC无关;除颤前ETCO2的作用需要仔细考虑复苏期间使用的气道类型。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Predefibrillation end-tidal CO2 (ETCO2) may predict defibrillation success and could guide defibrillation timing in ventricular fibrillation (VF) cardiac arrest. This relationship has only been studied using advanced airways. Our aim was to evaluate this relationship using both basic (bag-valve-mask (BVM)) and advanced airways (supraglottic airways and endotracheal tubes).
METHODS: Prehospital patient records and defibrillator files were abstracted for patients with out-of-hospital cardiac arrest in Ontario, Canada, with initial VF cardiac rhythms between 1 January 2018, and 31 December 2019. Analyses assessed the relationship between each predefibrillation ETCO2 reading and defibrillation outcomes at the subsequent 2 min pulse check (ie, VF, asystole, pulseless electrical activity (PEA) or return of spontaneous circulation (ROSC)), accounting for airway types used during resuscitation. Multivariable logistic regression evaluated the association between the first documented predefibrillation ETCO2 and postshock VF termination or ROSC.
RESULTS: Of 269 cases abstracted, 153 had predefibrillation ETCO2 measurements and were included in the study. Among these cases, 904 shocks were delivered and 44.4% (n=401) had predefibrillation ETCO2 measured. The first ETCO2 reading was more often from BVM (n=134) than advanced airways (n=19). ETCO2 readings were lower when measured through BVM versus advanced airways (30.5 mm Hg (4.06 kPa) (±14.4 mm Hg (1.92 kPa)) vs 42.1 mm Hg (5.61 kPa) (±22.5 mm Hg (3.00 kPa)), adjANOVA p<0.01). Of all shocks with ETCO2 reading (n=401), no difference in preshock ETCO2 was found for subsequent shocks that resulted in persistent VF (32.2 mm Hg (4.29 kPa) (±15.8 mm Hg (2.11 kPa))), PEA (32.8 mm Hg (4.37 kPa) (±17.1 mm Hg (2.30 kPa))), asystole (32.4 mm Hg (4.32 kPa) (±20.6 mm Hg (2.75 kPa))) or ROSC (32.5 mm Hg (4.33 kPa) (±15.3 mm Hg (2.04 kPa))), analysis of variance p=0.99. In the multivariate analysis using the initial predefibrillation ETCO2, there was no association with VF termination on the subsequent shock (adjusted OR (adjOR) 0.99, 95% CI 0.97 to 1.02, p=0.57) or ROSC (adjOR 1.00, 95% CI 0.97 to 1.03, p=0.94) when evaluated as a continuous or categorical variable.
CONCLUSION: Predefibrillation ETCO2 measurement is not associated with VF termination or ROSC when basic and advanced airways are included in the analysis. The role of predefibrillation ETCO2 requires careful consideration of the type of airway used during resuscitation.
参考来源
- Kwong JL, Drennan IR, Turner L, et al. Predefibrillation end-tidal CO2 and defibrillation success in out-of-hospital cardiac arrest: an observational cohort study. Emerg Med J. 2022. PMID: 36171074. doi:10.1136/emermed-2021-211951
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。